Gut 2008;57:674-683
Recent advances in basic science
Visceral hypersensitivity in non-erosive reflux disease
1 Neurogastroenterology Group, Centres for Academic Surgery, Institute of Cellular and Molecular Science, Barts and the London, Queen Marys School of Medicine and Dentistry, Whitechapel, London, UK
2 Centres for Gastroenterology, Institute of Cellular and Molecular Science, Barts and the London, Queen Marys School of Medicine and Dentistry, Whitechapel, London, UK
Mr Charles H Knowles, Barts and the London NHS Trust and the Homerton University NHS Foundation Trust, Centre for Academic Surgery, 3rd Floor Alexandra Wing, Royal London Hospital, London E1 1BB, UK; c.h.knowles@qmul.ac.uk
Revised version received 7 November 2007
Accepted 3 December 2007
| The first 150 words of the full text of this article appear below. |
Non-erosive reflux disease (NERD) is defined as the presence of classic symptoms of gastro-oesophageal reflux disease (GORD) in the absence of oesophageal mucosal injury (or Barretts oesophagus) as determined by inspection at upper gastrointestinal endoscopy.1 As such it is regarded as being one of the two main phenotypes of GORD, the other being erosive oesophagitis (EO) where ulceration or erosions are evident. GORD is common, with estimates of 20–44% of Western populations having symptoms of GORD at least once a month and 20% weekly.2 The proportion of such patients with NERD is estimated to be between 503 and 70%.4 It is acknowledged that responses to standard acid suppressive treatments are 20–30% lower in patients with NERD than those with EO.5 Considering this, and the high prevalence of NERD, which is likely to increase in parallel with societal body mass index,6 the pathophysiological understanding of this condition remains a priority.
The
This article has been cited by other articles:
-
Farmer, A. D., Aziz, Q.
(2009). Visceral pain hypersensitivity in functional gastrointestinal disorders. Br Med Bull
91: 123-136
[Abstract] [Full Text] -
Kinoshita, Y., Ishihara, S.
(2008). Review: Causes of, and therapeutic approaches for, proton pump inhibitor-resistant gastroesophageal reflux disease in Asia. Therapeutic Advances in Gastroenterology
1: 191-199
[Abstract]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
